Menstrual Blood Revolutionizes Diagnostics
The FDA approved a groundbreaking diagnostic tool in early 2024: the Q-Pad, which uses menstrual blood to measure blood sugar levels. This organic cotton pad collects menstrual blood for laboratory analysis of A1C biomarkers, providing insights into average blood sugar over three weeks. The technology could expand to detect HPV, endometriosis, and other conditions. This non-invasive approach transforms routine menstruation into a valuable diagnostic opportunity, potentially revolutionizing women’s health monitoring.